ChemicalBook >> CAS DataBase List >>Bendroflumethiazide

Bendroflumethiazide

CAS No.
73-48-3
Chemical Name:
Bendroflumethiazide
Synonyms
ft8;bhft;ft81;relan;urlea;blh368;centyl;nikion;orsile;pluryl
CBNumber:
CB3233276
Molecular Formula:
C15H14F3N3O4S2
Molecular Weight:
421.41
MDL Number:
MFCD00078963
MOL File:
73-48-3.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-09-12 18:51:51

Bendroflumethiazide Properties

Melting point 205-207°C
Boiling point 602.1±65.0 °C(Predicted)
Density 1.4711 (estimate)
storage temp. Refrigerator
solubility Practically insoluble in water, freely soluble in acetone, soluble in ethanol (96 per cent).
pka pKa 8.53±0.05(H2O t=25 I=0.2) (Uncertain)
form Solid
color Crystals from MeOH/CHCl3
Water Solubility 40mg/L(room temperature)
FDA UNII 5Q52X6ICJI
ATC code C03AA01
EPA Substance Registry System 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide (73-48-3)

Pharmacokinetic data

Protein binding 94%
Excreted unchanged in urine 30%
Volume of distribution 1.2-1.5(L/kg)
Biological half-life 3-9 / -

SAFETY

Risk and Safety Statements

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H332-H302
Precautionary statements  P261-P271-P304+P340-P312-P264-P270-P301+P312-P330-P501
WGK Germany  2
RTECS  DK8225000
HS Code  2935904000
Hazardous Substances Data 73-48-3(Hazardous Substances Data)
Toxicity LD50 oral in mouse: > 10gm/kg

Bendroflumethiazide price More Price(29)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich BP967 Bendroflumethiazide British Pharmacopoeia (BP) Reference Standard 73-48-3 100MG $256 2026-04-30 Buy
Sigma-Aldrich B0400000 Bendroflumethiazide European Pharmacopoeia (EP) Reference Standard 73-48-3 100 mg $127 2026-04-30 Buy
Sigma-Aldrich 1049000 Bendroflumethiazide United States Pharmacopeia (USP) Reference Standard 73-48-3 200mg $416 2026-04-30 Buy
Sigma-Aldrich B5775 Bendroflumethiazide analytical standard 73-48-3 1g $59.7 2025-07-31 Buy
Cayman Chemical 21311 Bendroflumethiazide ≥98% 73-48-3 1mg $49 2026-04-30 Buy
Product number Packaging Price Buy
BP967 100MG $256 Buy
B0400000 100 mg $127 Buy
1049000 200mg $416 Buy
B5775 1g $59.7 Buy
21311 1mg $49 Buy

Bendroflumethiazide Chemical Properties, Uses, Production

Description

Bendroflumethiazide (Item No. 21311) is an analytical reference standard categorized as a diuretic. Diuretics, including bendroflumethiazide, have been abused as performance-enhancing drugs and masking agents in sports doping. This product is intended for research and forensic applications.

Chemical Properties

White Solid

Originator

Naturetin,Squibb,US,1959

Uses

Bendroflumethiazide may be used for the same indications as the aforementioned drugs; however, it is primarily used as an adjuvant agent for relieving edema associated with cardiac insufficiency, liver cirrhosis, and edema caused by taking corticosteroids.

Uses

Diuretic; antihypertensive.

Uses

expectorant

Definition

ChEBI: A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Manufacturing Process

The process is described in US Patent 3,392,168 as follows:
(A) Preparation of 5-Trifluoromethylaniline-2,4-Disulfonylchloride - 113 ml of chlorosulfonic acid is cooled in an ice bath, and to the acid is added dropwise while stirring 26.6 grams of α,α,α-trifluoro-m-toluidine. 105 grams of sodium chloride is added during 1-2 hours, where after the temperature of the reaction mixture is raised slowly to 150° - 160°C which temperature is maintained for three hours. After cooling the mixture, ice-cooled water is added, whereby 5-trifluoromethylaniline-2,4-disulfonyl chloride separates out from the mixture.
(B) Preparation of 5-Trifluoromethyl-2,4-Disulfamylaniline - The 5- trifluoromethylaniline-2,4-disulfonyl chloride obtained in step (A) is taken up in ether and the ether solution dried with magnesium sulfate. The ether is removed from the solution by distillation, the residue is cooled to 0°, and 60 ml of ice-cooled, concentrated ammonia water is added while stirring. The solution is then heated for one hour on a steam bath and evaporated in vacuo to crystallization. The crystallized product is 5-trifluoromethyl-2,4- disulfamylaniline, which is filtered off, washed with water and dried in a vacuum-desiccator over phosphorus pentoxide. After recrystallization from a mixture of 30% ethanol and 70% water, the compound has a MP of 247°- 248°C.
(C) Preparation of 3-Benzyl-6-Trifluoromethyl-7-Sulfarnyl-3,4-Dihydro-1,2,4- Benzothiadiazine-1,1-Dioxide - 6.4 grams of 5-trifluoromethyl-2,4- disulfamylaniline is dissolved in 12 ml of dioxane, 2.7 ml of phenylacetaldehyde and a catalytic amount of p-toluenesulfonic acid are added. After boiling for a short time under reflux, the reaction mixture crystallizes, and, after filtration and recrystallization from dioxane, the desired product is obtained with a MP of 224.5°-225.5°C.
(D) Alternative to (C) - 9.6 grams of 5-trifluoromethyl-2,4-disulfarnylaniline and 4.9 grams of ω-ethoxystyrene are dissolved in 35 ml of n-butanol. 0.5 grams of p-toluenesulfonic acid is added, and the mixture is heated on a steam bath while stirring. When the solution is clear, 55 ml of hexane is added, whereafter the mixture is heated further for one and a half hours. After cooling, the substance identical to that of Example (C) is filtered off and has a MP of 222°-223°C.
Sterile compositions containing Bendroflumethiazide for parenteral administration may be prepared as described in US Patent 3,265,573.

brand name

Naturetin (Apothecon).

Therapeutic Function

Diuretic, Antihypertensive

Clinical Use

Thiazide diuretic:

Hypertension

Oedema

Safety Profile

Poison by intravenous route.Human systemic effects by ingestion: convulsions andsomnolence. Mutation data reported. When heated todecomposition it emits toxic fumes of F-, SOx, and NOx.

Synthesis

Bendroflumethiazide, 1,1-dioxide 3-benzyl-6-(trifluoromethyl)- 3,4-dihydro-2H-1,2,4-benzothiadiazin-7-sulfonamide (21.3.6), is synthesized by the same scheme of making the aforementioned drugs using phenylacetaldehyde or its acetale as a carbonyl component, and using 2,4-disulfonamido-5-trifluoromethylaniline (21.3.5) as an o-aminosulfonamide component.

Synthesis_73-48-3

Drug interactions

Potentially hazardous interactions with other drugs
Analgesics: increased risk of nephrotoxicity with NSAIDs; antagonism of diuretic effect.
Anti-arrhythmics: hypokalaemia leads to increased cardiac toxicity; effects of lidocaine and mexiletine antagonised.
Antibacterials: avoid administration with lymecycline.
Antidepressants: increased risk of hypokalaemia with reboxetine; enhanced hypotensive effect with MAOIs; increased risk of postural hypotension with tricyclics.
Antiepileptics: increased risk of hyponatraemia with carbamazepine.
Antifungals: increased risk of hypokalaemia with amphotericin.
Antihypertensives: enhanced hypotensive effect; increased risk of first dose hypotension with postsynaptic alpha-blockers like prazosin; hypokalaemia increases risk of ventricular arrhythmias with sotalol.
Antipsychotics: hypokalaemia increases risk of ventricular arrhythmias with amisulpride; enhanced hypotensive effect with phenothiazines; hypokalaemia increases risk of ventricular arrhythmias with pimozide - avoid.
Atomoxetine: hypokalaemia increases risk of ventricular arrhythmias.
Cardiac glycosides: increased toxicity if hypokalaemia occurs.
Ciclosporin: increased risk of nephrotoxicity and hypomagnesaemia. Cytotoxics: increased risk of ventricular arrhythmias due to hypokalaemia with arsenic trioxide; increased risk of nephrotoxicity and ototoxicity with platinum compounds. Lithium excretion reduced, increased toxicity.

Metabolism

There are indications that bendroflumethiazide is fairly extensively metabolised. About 30% is excreted unchanged in the urine with the remainder excreted as uncharacterised metabolites.

References

[1] D S MAJID  L G N. Blockade of distal nephron sodium transport attenuates pressure natriuresis in dogs.[J]. Hypertension, 1994, 23 6 Pt 2: 1040-1045. DOI: 10.1161/01.hyp.23.6.1040
[2] VONGPATANASIN W. Hydrochlorothiazide is not the most useful nor versatile thiazide diuretic.[J]. Current Opinion in Cardiology, 2015, 30 4: 361-365. DOI: 10.1097/hco.0000000000000178

Bendroflumethiazide Preparation Products And Raw materials

Global Suppliers ( 166)
Supplier Tel Email Country ProdList Advantage
Chemsky(shanghai)International Co.,Ltd. 021-50135380 shchemsky@sina.com China 32273 50
Syntechem Co.,Ltd info@syntechem.com China 12973 57
Sinopharm Chemical Reagent Co,Ltd. 86-21-63210123 sj_scrc@sinopharm.com China 9791 79
Artis Chemistry (Shanghai) Co. Ltd. 86-21-60936353 China 335 58
Beijing HuaMeiHuLiBiological Chemical 010-56205725 waley188@sohu.com China 12323 58
Shanghai Aladdin Bio-Chem Technology Co.,LTD 400-6206333 13167063860 anhua.mao@aladdin-e.com China 29985 65
Nanjing Sunlida Biological Technology Co., Ltd. 025-57798810 18652991625 sales@sunlidabio.com China 3223 55
Vientiane Tianjin Hengyuan Technology Co., Ltd. 15722085254 phytochemical@126.com China 813 55
Quality Control Solutions Ltd. 0755-66853366 13670046396 orders@qcsrm.com China 18188 56
Sichuan Wei Keqi Biological Technology Co., Ltd. 028-81700200 18116577057 3003855609@qq.com China 7717 56

View Latest Price from Bendroflumethiazide manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Bendroflumethiazide  Impurity pictures 2025-12-16 Bendroflumethiazide Impurity
73-48-3
10mg 98 100000 Moxin Chemicals
BENDROFLUMETHIAZIDE pictures 2023-09-11 BENDROFLUMETHIAZIDE
73-48-3
$80.00 1kg 99% 10000tons Anhui Ruihan Technology Co., Ltd
BENDROFLUMETHIAZIDE pictures 2019-07-06 BENDROFLUMETHIAZIDE
73-48-3
$7.00 1kg 99% 100kg Career Henan Chemical Co

Bendroflumethiazide Spectrum

BENDROFLUMETHIAZIDE-D5 1,1-dioxo-3-(phenylmethyl)-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 3-(benzyl)-1,1-diketo-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide rac Bendroflumethiazide Bendroflumethiazide (200 mg) Bendroflumethiazide (200 mg)H0C4020.994mg/mg(ai) 6-trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine,1,1 aprinox be724-a bendrofluazide bendroflumethazide bendroflumethiazid bentride benuron benzhydroflumethiazide benzydroflumethiazide benzylhydroflumethiazide benzylrodiuran berkozide bhft blh368 bristuric bristuron centyl flumesil ft8 ft81 intolex livesan mide1,1-dioxide nateretin naturetin naturine neonaclex neo-naclex neo-rontyl niagaril nikion oromethyl)-,1,1-dioxide orsile pluryl pluryle plusuril poliuron relan relanbeta repicin salural salures sinesalin sodiuretic thiazidico urlea 3-BENZYL-6-TRIFLUOROMETHYL-7-SULFAMOYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE 2h-1,2,4-benzothiadiazine-7-sulfonamide,3,4-dihydro-3-(phenylmethyl)-6-(triflu 2h-1,2,4-benzothiadiazine-7-sulfonamide,3-benzyl-3,4-dihydro-6-(trifluoromethy 3-benzyl-3,4-dihydro-6-(trifluoromethyl)-2h-1,2,4-benzothiadiazine-7-sulfona 3-benzyl-6-trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine,1